Immediate aortic obstruction in young infants undergoing patent arterial duct closure with the duct occluder

Taniya Rachel Issacs1, Navaneetha Sasikumar1, Raman Krishna Kumar1

  • 1Department of Pediatric Cardiology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.

PubMed

Insights

Device displacement after patent ductus arteriosus (PDA) closure in infants can cause aortic obstruction. Exaggerated device recoil and tissue pliability are key factors, necessitating careful pre-deployment assessment.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Biomedical Engineering

Background:

  • Patent ductus arteriosus (PDA) is a common congenital heart defect in infants.
  • Transcatheter device closure is a frequent treatment for PDA.
  • Device migration after PDA closure can lead to serious complications.

Purpose of the Study:

  • To investigate the causes of immediate device displacement into the aorta after PDA closure in young infants.
  • To identify factors contributing to device migration and subsequent aortic obstruction.

Main Methods:

  • Retrospective analysis of three infants with PDA who experienced device displacement after duct occluder deployment.
  • Comparison of device recoil (percentage shortening screw to pin distance ratio) between cases and 15 control infants with uneventful PDA closure.
  • Analysis of aortic diameter and PDA length in cases and controls.

Main Results:

  • Three young infants experienced immediate device displacement into the aorta after duct occluder deployment, requiring urgent surgical intervention.
  • The percentage shortening screw to pin distance ratio, indicating device recoil, was significantly higher in cases (14.00 [12-15]) compared to controls (4.00 [2.30-7.50]), P = 0.011.
  • Aortic diameter and PDA length were similar between cases and controls.

Conclusions:

  • A combination of tissue pliability and exaggerated device recoil can lead to device migration and aortic obstruction in small infants undergoing PDA closure.
  • Cautious assessment of device deployment and immediate post-release evaluation are crucial in young infants to prevent complications.